Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase 1 pseudogene 12 (PGAM1P12) is classified as a pseudogene in the human genome[1]. Pseudogenes are DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition and have lost the ability to encode functional proteins due to mutations or deletions. PGAM1P12 shares homology with the phosphoglycerate mutase 1 gene (PGAM1), which encodes an active enzyme involved in glycolysis[2][3], but PGAM1P12 itself does not produce a functional protein and is not expressed as part of known biological pathways nor implicated in disease. PGAM1P12 should not be confused with the functional enzyme phosphoglycerate mutase 1 (PGAM1), which is an established metabolic enzyme and therapeutic target, particularly in cancer research[4][3]. As a pseudogene, PGAM1P12 lacks biological activity and is not considered a true molecular target.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 12 (PGAM1P12).